Lymphocyte Antigen 6 Complex Plays A Crucial Role in Diseases

Target Name: Lymphocyte antigen 6 complex

NCBI ID: P45436

Lymphocyte antigen 6 complex

Other Name(s): Ly-6

Lymphocyte Antigen 6 Complex Plays A Crucial Role in Diseases

Lymphocyte antigen 6 complex (Ly-6), also known as CD11b, is a cell surface glycoprotein that is expressed in a variety of tissues, including lymphocytes, where it is involved in cell adhesion, migration, and signaling. The Ly-6 protein has also been implicated in inflammation, immune surveillance, and cancer.

Recent studies have suggested that Ly-6 may be a potential drug target or biomarker for a variety of diseases, including cancer, autoimmune disorders, and inflammatory diseases. This is because the Ly-6 protein has been shown to play a critical role in the regulation of these conditions, and its dysfunction may contribute to the development and progression of these diseases.

One of the key mechanisms through which Ly-6 contributes to disease development is its role in the regulation of cell-surface interactions. Ly-6 is involved in the formation of tight junctions, which are critical for maintaining tissue structure and preventing penetration. Additionally, Ly-6 is involved in the regulation of adhesion, which is critical for the maintenance of tissue integrity and the development of tissues.

In cancer, Ly-6 has been shown to be involved in the regulation of cell adhesion and migration. For example, studies have shown that Ly-6 is involved in the regulation of the migration of breast cancer cells. Additionally, Ly-6 has has been shown to be involved in the regulation of the adhesion of cancer cells to blood vessels, which may contribute to the development of cancer.

In autoimmune disorders, Ly-6 has been implicated in the regulation of immune cell function. For example, studies have shown that Ly-6 is involved in the regulation of the activation and proliferation of T cells, which are critical for the development of autoimmune disorders. Additionally, Ly-6 has been shown to be involved in the regulation of the regulation of immune cell function, which may contribute to the development and progression of autoimmune disorders.

In conclusion, lymphocyte antigen 6 complex (Ly-6) is a cell surface glycoprotein that is involved in a variety of physiological processes, including cell adhesion, migration, and signaling. Recent studies have suggested that Ly-6 may be a potential drug target or biomarker for a variety of diseases, including cancer, autoimmune disorders, and inflammatory diseases. Further research is needed to fully understand the role of Ly-6 in these conditions and to develop effective treatments.

Protein Name: Lymphocyte Antigen 6 Complex (nonspecified Subtype)

The "Lymphocyte antigen 6 complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Lymphocyte antigen 6 complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets